Going Concern (worsened) — Going-concern doubt persists; basis changed from cash insufficiency to contingent cash settlement obligations under Series B Preferred Stock that could exceed available cash.

NASDAQ: SNSE Sensei Biotherapeutics, Inc. 10-Q

Sensei acquires Faeth for $133M, raises $200M, pivots to PIKTOR; solnerstotug deprioritized

Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 6, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SNSE commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · May 25, 2026 9:10 AM